» Articles » PMID: 35183538

Hippocampal NR6A1 Impairs CREB-BDNF Signaling and Leads to the Development of Depression-like Behaviors in Mice

Overview
Specialties Neurology
Pharmacology
Date 2022 Feb 20
PMID 35183538
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic stress exposure is a risk factor that can induce the development of depression-like behaviors by impairing the hippocampal cyclic adenosine monophosphate-response element binding protein (CREB)-brain-derived neurotrophic factor (BDNF) signaling, but its underlying mechanisms remain largely unknown. We identified an orphan receptor that can suppress the activity of CREB, nuclear receptor sub-family 6, group A, member 1 (NR6A1), in mouse brain neurons. Given the critical role of the impaired CREB-BDNF signaling in depression, we speculate that the neuronal NR6A1 may mediate the pathogenesis of depression. Results showed that chronic unpredictable stress (CUS) markedly increased the expression levels of hippocampal NR6A1 protein, which reduced hippocampal CREB phosphorylation and BDNF protein expression. Overexpression of hippocampal NR6A1 in stress-naïve mice simulated chronic stress, inducing depression-like behaviors in the tail suspension test, forced swimming test, and sucrose preference test, and impairing the hippocampal CREB-BDNF signaling cascade. Genetic knockdown of hippocampal NR6A1 did not affect mouse behaviors but prevented the CUS-induced depression-like behaviors in mice and impairment in hippocampal CREB-BDNF signaling. Furthermore, genetic knockdown of hippocampal CREB or BDNF abrogated the preventive effect of hippocampal NR6A1 down-regulation on CUS-induced depression-like behaviors in mice. Collectively, these results for the first time identified a nuclear expression of NR6A1 in mouse brain neurons, and showed that the abnormally increased NR6A1 protein in the hippocampus in mice treated with or without chronic stress can impair the CREB-BDNF signaling cascade and lead to the development of depression-like behaviors. Hippocampal NR6A1 could be a novel target for the development of antidepressants.

Citing Articles

Alpha-synuclein Fibrils Inhibit Activation of the BDNF/ERK Signaling Loop in the mPFC to Induce Parkinson's Disease-like Alterations with Depression.

Ma Z, Xu Y, Lian P, Wu Y, Liu K, Zhang Z Neurosci Bull. 2024; .

PMID: 39609371 DOI: 10.1007/s12264-024-01323-x.


Mitofusin 2 Mediates the Protective Effect of NR6A1 Silencing Against Neuronal Injury in Experimental Stroke Models.

Xu B, Liu Z, Chen K, Zhao Q, Wen H, Lin J Mol Neurobiol. 2024; .

PMID: 39259438 DOI: 10.1007/s12035-024-04466-0.


Preventive and therapeutic effect of vitamin D on depression-like behavior in a mouse adolescent depression model and its association with BDNF protein expression.

Yang X, Miao J, Huang Y, Li L, Zhuang G Front Psychiatry. 2024; 15:1425681.

PMID: 39135986 PMC: 11317463. DOI: 10.3389/fpsyt.2024.1425681.


Identification of neural-relevant toxcast high-throughput assay intended gene targets: Applicability to neurotoxicity and neurotoxicant putative molecular initiating events.

Mack C, Tsui-Bowen A, Smith A, Jensen K, Kodavanti P, Moser V Neurotoxicology. 2024; 103:256-265.

PMID: 38977203 PMC: 11895836. DOI: 10.1016/j.neuro.2024.07.001.


CREB: A Promising Therapeutic Target for Treating Psychiatric Disorders.

Guan W, Ni M, Gu H, Yang Y Curr Neuropharmacol. 2024; 22(14):2384-2401.

PMID: 38372284 PMC: 11451321. DOI: 10.2174/1570159X22666240206111838.